EUVIMEDEUVIMED entdecken
Fallbericht

ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma

Maggie P Fu iD, Mehul Sharma iD, Pariya Yousefi iD, Sarah M Merrill iD, Ryan Tan iD, Simran Samra iD, Audi Setiadi iD, Liam Golding iD, Bhavi P Modi iD, Kate L Del Bel iD, Rebecca J Deyell iD, Jacob Rozmus iD und 27 weitere

Journal of Experimental Medicine · 2025

DOI: 10.1084/jem.20240945 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Maggie P Fu und 38 weiteren Autor:innen. Beteiligte Einrichtung: British Columbia Children's Hospital, Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia …. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: CIHR, Genome British Columbia, Michael Smith Health Research BC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inborn errors of immunity (IEIs) are caused by deleterious variants in immune-related genes. ASXL1 is an epigenetic modifier not previously linked to an IEI. Clonal hematopoiesis and hematologic neoplasms often feature somatic ASXL1 variants, and Bohring–Opitz syndrome, a neurodevelopmental disorder, is caused by heterozygous truncating ASXL1 variants. We present an IEI caused by biallelic germline missense variants in ASXL1. The patient had a history of hematologic abnormalities and viral-associated complications, including chronic macrocytosis, persistent vaccine-strain rubella granulomas, and EBV-associated Hodgkin lymphoma. Immunophenotyping revealed loss of B cells, hypogammaglobulinemia, and impairments in cytotoxic T and NK cell populations. T cells exhibited skewing toward an exhausted memory phenotype, global DNA methylation loss, and increased epigenetic aging. These aberrations were ameliorated by wild-type ASXL1 transduction, confirming the patient variants’ pathogenicity. This study defines a novel human IEI caused by ASXL1 deficiency, a diagnosis that should be considered in individuals with chronic viral infections, viral-associated malignancies, and combined immune deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticEpstein-Barr Virus InfectionsHerpesvirus 4, HumanImmunologic Deficiency SyndromesLymphomaRepressor ProteinsHumansDNA Methylation

Substanzen

ASXL1 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • British Columbia Children's Hospital, Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia , Vancouver, Canada.
  • Edwin S.H. Leong Centre for Healthy Aging, University of British Columbia , Vancouver, Canada.
  • Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, Canada.
  • Department of Psychiatry and Human Behavior, The Warren Alpert Medical School at Brown University, Providence, RI, USA.
  • Experimental Medicine Program, Department of Medicine, The University of British Columbia , Vancouver, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

ORCID-Profile: Maggie P Fu, Mehul Sharma, Pariya Yousefi, Sarah M Merrill, Ryan Tan, Simran Samra, Audi Setiadi, Liam Golding, Bhavi P Modi, Kate L Del Bel, Rebecca J Deyell, Jacob Rozmus, Wingfield Rehmus, Kyla J Hildebrand, Elliot James, Géraldine Blanchard-Rohner, Susan Lin, Kevin E Shopsowitz, Jefferson Terry, Anna F Lee, Britt I Drögemöller, Allison Matthews, Maja Tarailo-Graovac, Laura Sauvé, Hana Mitchell, Julie S Prendiville, Julia L MacIsaac, Kristy Dever, David T S Lin, Mandy Meijer, Colin J D Ross, Simon R M Dobson, Suzanne M Vercauteren, Wyeth W Wasserman, Clara D M van Karnebeek, Margaret L McKinnon, Michael S Kobor, Stuart E Turvey, Catherine M Biggs

Förderung

  • CIHR
  • Genome British Columbia
  • Michael Smith Health Research BC
  • BC Children's Hospital Foundation and the Mining for Miracles initiative
  • Canadian Institutes of Health Research
  • BC Children’s Hospital Foundation and the Mining for Miracles initiative

Zitieren

APA

Fu, M. P., Sharma, M., Yousefi, P., Merrill, S. M., Tan, R., Samra, S., Setiadi, A., Golding, L., Modi, B. P., Del Bel, K. L., Deyell, R. J., Rozmus, J., Rehmus, W., Hildebrand, K. J., James, E., Blanchard-Rohner, G., Lin, S., Shopsowitz, K. E., Terry, J., …, & Biggs, C. M. (2025). ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240945

Vancouver

Fu MP, Sharma M, Yousefi P, Merrill SM, Tan R, Samra S, et al. ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20240945

BibTeX
@article{Fu2025,
  author = {Fu, Maggie P and Sharma, Mehul and Yousefi, Pariya and Merrill, Sarah M and Tan, Ryan and Samra, Simran and Setiadi, Audi and Golding, Liam and Modi, Bhavi P and Del Bel, Kate L and Deyell, Rebecca J and Rozmus, Jacob and Rehmus, Wingfield and Hildebrand, Kyla J and James, Elliot and Blanchard-Rohner, Géraldine and Lin, Susan and Shopsowitz, Kevin E and Terry, Jefferson and Lee, Anna F and Drögemöller, Britt I and Matthews, Allison and Tarailo-Graovac, Maja and Sauvé, Laura and Mitchell, Hana and Prendiville, Julie S and MacIsaac, Julia L and Dever, Kristy and Lin, David T S and Meijer, Mandy and Ross, Colin J D and Dobson, Simon R M and Vercauteren, Suzanne M and Wasserman, Wyeth W and van Karnebeek, Clara D M and McKinnon, Margaret L and Kobor, Michael S and Turvey, Stuart E and Biggs, Catherine M},
  title = {ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1084/jem.20240945}
}
Kostenlos starten →